All posts tagged "leronlimab"

• 

  1.2K

  2

  Biotech

  CytoDyn’s Preliminary Phase 1b/2 Cancer Results Likely to Receive Breakthrough Therapy Designation (BTD)

  CytoDyn Inc. (OTCMKTS: CYDY) announced excellent preliminary results from its Phase 1b/2 clinical trial in metastatic triple negative breast cancer (mTNBC) that...

• 

  1.3K

  Biotech

  CytoDyn (CYDY) at Crossroads: Past and Current Leadership Collide in Epic Grudgematch

  Latest 8-K filing settles dispute for $7.6 million but paves way for Pestell share repurchase at par 13-D Group is outspoken but...

• 

  1.5K

  Biotech

  CytoDyn FDA Letter is Old News – International Still Progressing

  CytoDyn Inc (OTCMKTS: CYDY) shareholders got a real gut check yesterday as the STAT writer Adam Feuerstein sent out a tweet at...

• 

  1.9K

  Biotech

  CytoDyn’s Adjust Course to Emphasize Philippine EUA and Long Haulers

  Many CytoDyn Inc. (OTCMKTS: CYDY) shareholders have been waiting impatiently for an EUA from the US FDA and a BLA in HIV. ...

• 

  1.8K

  Biotech

  COVID Stocks Popping in Sympathy with Positive Humanigen Top Line Data

  Humanigen Inc. (NASDAQ: HGEN) released excellent news that their drug lenzilumab improved survival without the need for invasive mechanical ventilation (IMV) by...

• 

  3.0K

  3

  Biotech

  CytoDyn Saves Lives & Reduces COVID-19 Hospital Duration

  6 endpoints met after full data release so shorts double down on trial failure narrative  Investors in CytoDyn Inc. (OTCMKTS: CYDY) are...

• 

  13.5K

  Biotech

  RISE of the COVID-19 Therapeutics CytoDyn (OTCMKTS: CYDY) & Humanigen (NASDAQ:HGEN)

  Enrollment Key Metric in Therapeutic Race Philippines EUA Relevant to CytoDyn, not Humanigen Highly Credentialed Humanigen Team Possibility of NASDAQ Uplisting for...

• 

  13.1K

  1

  Biotech

  CytoDyn (OTCMKTS: CYDY) Subtly Signals Pivot Into Philippines and Vaccine Market

  On Sunday Night CytoDyn Inc. (OTCMKTS:CYDY) quietly placed a link in their developing news section to a 2016 medical journal article that...

• 

  11.3K

  Biotech

  Handicapping CytoDyn’s (OTCMKTS: CYDY) Interim Readout

  Powerful recommendation from DSMB Imminent on Leronlimab Numbers are not part of any Interim report unless a statistical penalty is taken  A...

• 

  11.0K

  1

  Biotech

  All Eyes On CytoDyn Now That Trump Has COVID-19

  Just now, markets are waking up to the news that President Donald Trump and First Lady Melanie have tested positive for COVID-19....